Academician and vice chairman of the Standing up Committee of the National Peoples Congress.

AstraZeneca Enhances Clinical Study Capabilities in China AstraZeneca today announced a strategic partnership with Peking University 3rd Medical center to open its initial Clinical Pharmacology Device in China. The machine aims to improve local clinical research features and speed up usage of new medicines to advantage Chinese individuals. Han Qide, academician and vice chairman of the Standing up Committee of the National People’s Congress; Sang Guowei, President of China Pharmaceutical Association; Chen Zhongqiang, Dean of Peking University 3rd Medical center; and David Brennan, CEO of AstraZeneca, had been present at the starting ceremony revatio.biz/revatio-common-uses.html .